company background image
6919 logo

Caliway Biopharmaceuticals TWSE:6919 Stock Report

Last Price

NT$511.00

Market Cap

NT$71.2b

7D

5.6%

1Y

171.4%

Updated

05 Nov, 2024

Data

Company Financials +

Caliway Biopharmaceuticals Co., Ltd.

TWSE:6919 Stock Report

Market Cap: NT$71.2b

6919 Stock Overview

Caliway Biopharmaceuticals Co.Ltd develops small molecule drugs for medical aesthetic and inflammatory disease.

6919 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth5/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Caliway Biopharmaceuticals Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Caliway Biopharmaceuticals
Historical stock prices
Current Share PriceNT$511.00
52 Week HighNT$800.00
52 Week LowNT$182.75
Beta0
11 Month Change-1.35%
3 Month Change-11.90%
1 Year Change171.45%
33 Year Changen/a
5 Year Changen/a
Change since IPO689.19%

Recent News & Updates

Companies Like Caliway Biopharmaceuticals (TWSE:6919) Can Afford To Invest In Growth

Oct 02
Companies Like Caliway Biopharmaceuticals (TWSE:6919) Can Afford To Invest In Growth

Recent updates

Companies Like Caliway Biopharmaceuticals (TWSE:6919) Can Afford To Invest In Growth

Oct 02
Companies Like Caliway Biopharmaceuticals (TWSE:6919) Can Afford To Invest In Growth

Shareholder Returns

6919TW PharmaceuticalsTW Market
7D5.6%-0.8%-1.0%
1Y171.4%9.3%36.0%

Return vs Industry: 6919 exceeded the TW Pharmaceuticals industry which returned 9.3% over the past year.

Return vs Market: 6919 exceeded the TW Market which returned 36% over the past year.

Price Volatility

Is 6919's price volatile compared to industry and market?
6919 volatility
6919 Average Weekly Movement7.8%
Pharmaceuticals Industry Average Movement4.7%
Market Average Movement5.5%
10% most volatile stocks in TW Market8.7%
10% least volatile stocks in TW Market2.9%

Stable Share Price: 6919's share price has been volatile over the past 3 months compared to the TW market.

Volatility Over Time: 6919's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of TW stocks.

About the Company

FoundedEmployeesCEOWebsite
2012n/aYufang Lingwww.caliway.com.tw

Caliway Biopharmaceuticals Co Ltd develops small molecule drugs for medical aesthetic and inflammatory disease. The company was founded in 2012 and is based in New Taipei City, Taiwan.

Caliway Biopharmaceuticals Co., Ltd. Fundamentals Summary

How do Caliway Biopharmaceuticals's earnings and revenue compare to its market cap?
6919 fundamental statistics
Market capNT$71.24b
Earnings (TTM)-NT$622.43m
Revenue (TTM)NT$35.52m

2,006x

P/S Ratio

-114.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6919 income statement (TTM)
RevenueNT$35.52m
Cost of RevenueNT$10.35m
Gross ProfitNT$25.16m
Other ExpensesNT$647.60m
Earnings-NT$622.43m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Nov 08, 2024

Earnings per share (EPS)-4.46
Gross Margin70.85%
Net Profit Margin-1,752.59%
Debt/Equity Ratio0%

How did 6919 perform over the long term?

See historical performance and comparison